Back to medications
Medication monograph

upadacitinib

JAK InhibitorsImmunomodulatorsJanus Kinase InhibitorsAntirheumatic AgentsDisease-modifying Antirheumatic AgentsJanus Kinase Inhibitor

Clinical reference

Product monograph

RINVOQ- upadacitinib tablet, extended releaseRINVOQ- upadacitinib solution

Brands & formulations

Family members

RINVOQ

Marketed
15 MGORALTABLET (EXTENDED-RELEASE)[ "upadacitinib" ]
Product monograph

RINVOQ

Marketed
30 MGORALTABLET (EXTENDED-RELEASE)[ "upadacitinib" ]
Product monograph

RINVOQ

Marketed
45 MGORALTABLET (EXTENDED-RELEASE)[ "upadacitinib" ]
Product monograph

Pricing

Price information

Rinvoq Tablet

Abbvie · 15 mg

30: $2574.2760: $5002.8490: $7502.84

Rinvoq Tablet

Abbvie · 30 mg

30: $5142.8660: $10285.7190: $15434.29

Classification

Chemical class
JAK Inhibitors
Clinical class
Immunomodulators, Janus Kinase Inhibitors
Banks class
Antirheumatic Agents, Disease-modifying Antirheumatic Agents, Janus Kinase Inhibitor